搜索临床试验以:Trilaciclib; HR-Negative Breast Cancer; Adjuvant Therapy
总计73813个结果
-
Northwestern UniversityNational Cancer Institute (NCI)完全的
-
Central European Cooperative Oncology Group完全的
-
European Organisation for Research and Treatment...完全的
-
Taiho Pharmaceutical Co., Ltd.完全的
-
University of California, San FranciscoNational Cancer Institute (NCI)完全的
-
Technical University of Munich未知
-
European Organisation for Research and Treatment...未知乳腺癌法国, 瑞士, 荷兰, 比利时, 意大利, 以色列, 德国, 英国, 葡萄牙, 西班牙, 智利, 波兰, 火鸡, 波斯尼亚和黑塞哥维那
-
Tokyo UniversityHuman Genome Center, Institute of Medical Science, University of Tokyo终止
-
AstraZenecaGerman Adjuvant Breast Cancer Group完全的
-
Institute of Cancer Research, United Kingdom未知
-
Tianjin Medical University未知
-
University of Vermont未知
-
Candiolo Cancer Institute - IRCCS招聘中
-
Institut de cancérologie Strasbourg Europe招聘中
-
Dana-Farber Cancer InstituteJohns Hopkins University; Translational Breast Cancer Research Consortium尚未招聘乳腺癌 | HER2阳性乳腺癌 | IV 期乳腺癌 | 乳腺癌女性 | 乳腺癌转移 | 雌激素受体阳性乳腺癌美国
-
Tianjin Medical University Cancer Institute and...Kingbio Medical (Beijing) Co., Ltd.尚未招聘难治性乳腺癌
-
Fondazione IRCCS Ca' Granda, Ospedale Maggiore...尚未招聘
-
H. Lee Moffitt Cancer Center and Research Institute招聘中
-
Beijing Geekgene Technology Co., LTD招聘中
-
University of Southern CaliforniaNational Cancer Institute (NCI)尚未招聘
-
The Christie NHS Foundation TrustRoyal Marsden NHS Foundation Trust; University College London Hospitals尚未招聘